Related Experiment Videos

Hepatitis C virus infection and the dialysis patient

Fabrizio Fabrizi1, Giovanna Lunghi, Sri Venkatesh Ganeshan

  • 1Division of Nephrology, Maggiore Hospital, IRCCS, Milan, Italy. fabrizi@policlinico.mi.it

Seminars in Dialysis
|September 28, 2007
PubMed

Insights

Hepatitis C virus (HCV) is common in dialysis patients, impacting liver health and survival. While interferon therapy shows promise, its use requires careful consideration, especially post-renal transplant.

Area of Science:

  • Nephrology
  • Hepatology
  • Virology

Background:

  • Hepatitis C virus (HCV) infection is prevalent in patients undergoing dialysis, posing a significant risk for liver disease.
  • Nosocomial spread remains a primary route of HCV acquisition in dialysis settings, despite blood product screening.
  • HCV infection negatively impacts the survival rates of patients with chronic kidney disease on dialysis.

Purpose of the Study:

  • To review the current understanding of Hepatitis C virus in dialysis patients.
  • To explore treatment options for HCV in this population, including interferon-based therapies.
  • To assess the implications of pre-renal transplant HCV treatment on post-transplant outcomes.

Main Methods:

  • Literature review of clinical trials and observational studies on HCV in dialysis patients.
  • Analysis of treatment efficacy and tolerance of interferon-based therapies.
  • Evaluation of outcomes following renal transplantation in patients with a history of HCV infection.

Main Results:

  • Dialysis patients may have higher response rates but lower tolerance to conventional interferon therapy.
  • Limited data exist on pegylated interferon and ribavirin for HCV in dialysis patients.
  • Pre-renal transplant antiviral therapy shows durable responses and potential benefits post-transplant.

Conclusions:

  • HCV management in dialysis patients requires tailored approaches due to unique challenges in efficacy and tolerance.
  • Successful pre-transplant HCV treatment may improve post-renal transplant outcomes, reducing complications like diabetes and glomerulonephritis.
  • Further research is needed on optimal antiviral strategies for HCV in the dialysis population, particularly with newer agents.

Related Concept Videos

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
164
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
367
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
573
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
1.2K
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
1.1K
Dialysis01:15

Dialysis

Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
1.6K